USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Medimatrix Inc.
Address:
14 Washington Rd #403-a
Princeton Jct, NJ 08550
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 4
SBIR Phase II $1,000,000.00 2

Award List:

THE TREATMENT OF PARTIAL OR FULL THICKNESS SURFACE WOUNDS IN THE FIELD AFTER TRAUMATIC INJURY WHEN EVACUATION IS DELAYED IS A SERIOUS PROBLEM DUE TO BLOOD LOSS AND INFECTION.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr james m pachence
Abstract:
The treatment of partial or full thickness surface wounds in the field after traumatic injury when evacuation is delayed is a serious problem due to blood loss and infection. initially, fluid loss due to bleeding can lead to shock. infection is a major risk especially when the injury is to be… More

INJECTABLE COLLAGEN MATRIX FOR SOFT TISSUE AUGMENTATION

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

INJECTABLE COLLAGEN MATRIX FOR SOFT TISSUE AUGMENTATION

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Type i collagen has been used in a wide variety of medical applications. the most successful application of type i collagen has been the subdermal implantation of soluble collagen for the repair of dermatological defects and the repair of full thickness wounds. however, the dermatological repair… More

DEVELOPMENT OF DACRON-COLLAGEN COMPOSITE FOR LIGAMENTS

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Many synthetic and biologically derived materials have been tested for use in tendon and ligament repair. both dacron and collagen have been shown to be biocompatible materials. dacron has been shown to have sufficient strength and resilience for use in ligament replacement; however, it is not an… More

DEVELOPMENT OF A TISSUE ANALOG FOR CARTILAGE REPAIR

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
James M Pachence
Abstract:
N/a

DEVELOPMENT OF A TISSUE ANALOG FOR CARTILAGE REPAIR

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
James M Pachence
Abstract:
Following injury, articular cartilage either fails to repaircompletely or repairs in such a manner that it loses its former biochemical and biomechanical characteristics-a problem that present treatment modalities are inadequate in addressing. previous reports by have demonstrated the viability of… More